Skip to content
Wegovy
-
EMA panel recommends approval for Novo Nordisk’s new Wegovy 7.2 mg single-dose pen
Wegovy® 7.2 mg is already available in the European Union for adults with obesity through three separate 2.4 mg injections administered weekly.